Abstract: The present invention relates to bifunctional compounds, the bifunctional compounds for use in molecular imaging and therapy, methods of molecular imaging using the bifunctional compounds and kits including the bifunctional compounds for use molecular imaging. The bifunctional compounds have a tripodal hydroxypyridinone chelating portion and may be conjugated to a targeting group so that the compounds target specific cells or tissues in a subject.
Type:
Grant
Filed:
November 11, 2011
Date of Patent:
September 22, 2015
Assignee:
King's College London
Inventors:
James Russell Ballinger, David Berry, Philip John Blower, Yongmin Ma, Gregory Edgar David Mullen
Abstract: A process for producing a collagen/hydroxyapatite (HA) composite scaffold comprises the steps of forming a homogenous suspension of collagen and HA in an acidic solution, lyophilizing the suspension until a desired final freezing temperature is reached to produce the composite scaffold, and optionally cross-linking the composite scaffold, wherein the ratio of HA to collagen is at least 1:10 (w/w). Also provided is a collagen/hydroxyapatite (HA) composite scaffold comprising a homogenous distribution of hydroxyapatite within a porous, crosslinked, collagen matrix, wherein the ratio of HA to collagen is at least 1:10 (w/w). Suitably, the composite scaffold has a porosity of at least 99% (v/v), and a compressive stiffness of at least 0.3 KPa. Composite scaffolds of the invention may be used to provide osteoconductive bone implants and tissue engineering implants.
Type:
Grant
Filed:
March 6, 2013
Date of Patent:
September 22, 2015
Assignee:
ROYAL COLLEGE OF SURGEONS IN IRELAND
Inventors:
Fergal Joseph O'Brien, John Patrick Gleeson, Niamh Plunkett
Abstract: Provided are antimicrobial agents produced from Burkholderia cepacia complex (Bcc) bacteria, in particular from bacteria which comprise a cluster of polyketide synthesis genes. Also provided is use of the antimicrobial agents in the treatment of disease. Further provided are methods for producing antimicrobials, methods for detecting antimicrobial producing bacterial strains and kits for use in the methods.
Type:
Grant
Filed:
August 12, 2009
Date of Patent:
September 22, 2015
Assignee:
UNIVERSITY COLLEGE CARDIFF CONSULTANTS LTD.
Abstract: The present invention relates to methods and kits for detecting active tuberculosis infection in a subject using serological techniques and a first agent capable of binding an IgG, IgA and/or IgM directed to the first protein present in or on a Mycobacterium tuberculosis membrane vesicle or a Bacillus Calmette-Guerin (BCG) membrane vesicle. Also provided are methods of treating a subject with an active tuberculosis disease.
Type:
Application
Filed:
October 10, 2013
Publication date:
September 17, 2015
Applicant:
ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY
Inventors:
Jacqueline Michele Achkar, Arturo Casadevall, Rafael Prados-Rosales, Anke Ziegengalg
Abstract: The invention relates to a method for producing a multi-layer collagen scaffold. The method generally comprises the steps of: preparing a first suspension of collagen and freezing or lyophilising the suspension to provide a first layer; optionally preparing a further suspension of collagen and adding the further suspension onto the layer formed in the previous step to form a further layer, and freezing or lyophilising the layers, wherein when the layer formed in the previous step is formed by lyophilisation the lyophilised layer is re-hydrated prior to addition of the next layer; optionally, repeating the aforementioned step to form one or more further layers; and preparing a final suspension of collagen and pouring the final suspension onto the uppermost layer to form a final layer, and freeze-drying the layers to form the multi-layer collagen composite scaffold.
Type:
Application
Filed:
May 29, 2015
Publication date:
September 17, 2015
Applicant:
ROYAL COLLEGE OF SURGEONS IN IRELAND
Inventors:
John P. GLEESON, Tanya J. LEVINGSTONE, Fergal J. O'BRIEN
Abstract: The application relates to a bilateral hearing assistance system comprising first and second hearing assistance devices a processing unit, which in a NORMAL mode of operation processes an input audio signal based on configurable processing parameters and provides a processed electric stimulation signal. The system further includes one or more stimulation units for—in a TEST mode delivers first and second electric TEST stimulation signals to output units of said first and second devices respectively. The application further relates to a method of fitting a bilateral hearing assistance system to a particular user. The disclosure provides a measure allowing an improved fitting of bilaterally implanted Cochlear Implant users. The system further includes an evaluation unit configured to analyze the recorded physiological response of the user and to provide an objective measure of the user's perception of said TEST stimulation signals.
Type:
Application
Filed:
March 10, 2015
Publication date:
September 17, 2015
Applicants:
University College London, Oticon Medical A/S
Inventors:
Jonathan LAUDANSKI, Jamie A. UNDURRAGA, Nick HAYWOOD, Torsten MARQUARDT, David McALPINE
Abstract: The invention provides a method of depleting anti-MHC antibodies in a sample comprising contacting said sample with one or more recombinant MHC molecules or functionally equivalent variants, derivatives or fragments thereof and removing at least the recombinant MHC molecules to which antibodies to said recombinant MHC molecules contained within the sample have bound. This method allows the depletion of one or more specific MHC particularly HLA allele antibodies from a sample.
Type:
Application
Filed:
March 16, 2015
Publication date:
September 17, 2015
Applicants:
OXFORD RADCLIFFE HOSPITAL NHS ("ORH") TRUST OF THE JOHN RADCLIFFE HOSPITAL, KING'S COLLEGE LONDON, GUY'S & ST. THOMAS' HOSPITAL NHS TRUST ("GST")
Inventors:
Martin BARNARDO, Andrea Harmer, Michael Bunce, Robert Vaughan, Kenneth Welsh
Abstract: A bifunctional shRNA-based composition and methods for knocking down the expression of the PDX-1 oncogene in target cells is described herein. The invention also provides methods to deliver the shRNA-containing expression vectors to target tissues overexpressing the PDX-1 oncogene.
Type:
Grant
Filed:
December 4, 2012
Date of Patent:
September 15, 2015
Assignees:
Strike Bio, Inc., Baylor College of Medicine
Inventors:
John J. Nemunaitis, Donald Rao, F. Charles Brunicardi
Abstract: The present invention generally relates to sub-diffraction limit image resolution and other imaging techniques, including imaging in three dimensions. In one aspect, the invention is directed to determining and/or imaging light from two or more entities separated by a distance less than the diffraction limit of the incident light. In some cases, the position of the entities can be determined in all three spatial dimensions (i.e., in the x, y, and z directions), and in certain cases, the position in all three dimensions can be determined to an accuracy of less than about 1000 nm. In some cases, the z positions may be determined using one of a variety of techniques that uses intensity information or focal information (e.g., a lack of focus) to determine the z position. Non-limiting examples of such techniques include astigmatism imaging, off-focus imaging, or multi-focal plane imaging.
Type:
Grant
Filed:
September 9, 2013
Date of Patent:
September 15, 2015
Assignee:
President and Fellows of Harvard College
Inventors:
Xiaowei Zhuang, Bo Huang, Wilfred M. Bates, Wenqin Wang
Abstract: A device that includes a scaffold composition and a bioactive composition with the bioactive composition being incorporated into or coated onto the scaffold composition such that the scaffold composition and/or a bioactive composition controls egress of a resident cell or progeny thereof. The devices mediate active recruitment, modification, and release of host cells from the material.
Type:
Grant
Filed:
March 24, 2014
Date of Patent:
September 15, 2015
Assignees:
President and Fellows of Harvard College, Regents of the University of Michigan
Inventors:
David J. Mooney, Omar Abdel-Rahman Ali, Eduardo Alexandre Barros E Silva, Hyun Joon Kong, Elliot Earl Hill, Jr., Tanyarut Boontheekul
Abstract: The invention features compositions comprising agents having cardiac protective activity isolated from epicardial progenitor cells and derivatives thereof, and methods for the use of such compositions.
Type:
Grant
Filed:
August 29, 2011
Date of Patent:
September 15, 2015
Assignee:
The University of Vermont and State Agriculture College
Abstract: The present invention provides for monodispersed dendrimers having a core, branches and periphery ends, wherein the number of branches increases exponentially from the core to the periphery end and the length of the branches increases exponentially from the periphery end to the core, thereby providing for attachment of chemical species at the periphery ends without exhibiting steric hindrance.
Type:
Grant
Filed:
January 29, 2013
Date of Patent:
September 15, 2015
Assignees:
UNIVERSITY OF MARYLAND, BALTIMORE, UNIVERSITY OF MARYLAND, COLLEGE PARK
Abstract: The present invention generally provides semiconductor substrates having submicronsized surface features generated by irradiating the surface with ultra short laser pulses. In one aspect, a method of processing a semiconductor substrate is disclosed that includes placing at least a portion of a surface of the substrate in contact with a fluid, and exposing that surface portion to one or more femtosecond pulses so as to modify the topography of that portion. The modification can include, e.g., generating a plurality of submicron-sized spikes in an upper layer of the surface.
Type:
Grant
Filed:
November 6, 2013
Date of Patent:
September 15, 2015
Assignee:
President And Fellows Of Harvard College
Abstract: Techniques are disclosed for providing a content selecting mode in electronic touch screen devices. The content may be, for instance, text, graphics, images, files, and/or other consumable content. The user can engage the mode with a combination of gestures and touch points on the touch screen. The combination may include, for example, one or two initial touch points at a desired starting location of the target content, followed by a dragging gesture with two or more touch points moving from that location to the desired end location of the target content, wherein content between the starting and end locations is highlighted or otherwise selected. In one example case, if the initial touch includes multiple touch points then selecting of the target content may commence immediately, while a single initial touch point causes selecting to commence after a brief hold or the addition of another touch point at the starting location.
Abstract: Embodiments of the invention relate to compounds and methods for controlling algal growth, for example, in bodies of water or surfaces exposed to algae. Provided are compounds having algicidal activities and methods of use of these compounds as well as formulations and compositions comprising the compound having algicidal activities.
Type:
Grant
Filed:
August 22, 2011
Date of Patent:
September 15, 2015
Assignee:
PRESIDENT AND FELLOWS OF HARVARD COLLEGE
Inventors:
Roberto Kolter, Rebecca Case, Jon Clardy, Mohammad Seyedsayamdost
Abstract: An apparatus for detecting the presence of a target molecule is disclosed which includes a conductive nanostructure, a non-conductive polymer coating on at least a portion of the nanostructure, and a cavity formed in the polymer coating having a shape corresponding to the shape of the target molecule. A property of the nanostructure depends on the presence of the target molecule at the cavity.
Abstract: Provided herein are methods and materials for diagnosing a subject's predisposition for pulmonary infection in a CF subject by detecting a pulmonary infection genetic marker. Pulmonary infection markers have been identified in the IL-1 gene cluster and may be useful in predicting CF disease progression and assessing a CF subject's response to therapy.
Type:
Grant
Filed:
November 15, 2011
Date of Patent:
September 15, 2015
Assignee:
Presidental and Fellows of Harvard College
Inventors:
Hara Levy, Craig Gerard, Gerald Pier, Scott Weiss, Christoph Lange
Abstract: Techniques are disclosed for providing a content selecting mode in electronic touch screen devices. The content may be, for instance, text, graphics, images, files, and/or other consumable content. The user can engage the mode with a combination of gestures and touch points on the touch screen. The combination may include, for example, multiple initial touch points within a given content block, followed by a dragging gesture that moves the touch points into or otherwise within the given content block, wherein the entire content block is then highlighted/selected. The initial touch points may touch, for instance, any piece of content within that block and the subsequent dragging gesture moves those initial touch points toward another piece of content within that block. As the drag continues into other blocks, so does selecting. The techniques can be used, for example, to select entire sentences or paragraphs or other content blocks.
Abstract: The present invention provides processes for producing porous silk fibroin scaffold material. The porous silk fibroin scaffold can be used for tissue engineering. The porosity of the silk fibroin scaffolds described herein can be adjusted as to mimic the gradient of densities found in natural tissue. Accordingly, methods for engineering of 3-dimensional tissue, e.g. bone and cartilage, using the silk fibroin scaffold material are also provided.
Type:
Grant
Filed:
February 14, 2013
Date of Patent:
September 15, 2015
Assignees:
Massachusetts Institute of Technology, Trustees of Tufts College
Inventors:
David L. Kaplan, Rina Nazarov, Gordana Vunjak-Novakovic, Lorenz Meinel
Abstract: Provided herein is a new class of cyclic lactadherin peptides (cLac) that mimic the natural phosphatidylserine (PS)-binding activity of the parent lactadherin protein. These cLacs are useful as small molecule indicators of early stage of apoptosis and of treatment efficacy evaluation.